Literature DB >> 185944

Antiviral action and cellular toxicity of four thymidine analogues: 5-ethyl-,5-vinyl-, 5-propyl-, and 5-allyl-2'- deoxyuridine.

Y C Cheng, B A Domin, R A Sharma, M Bobek.   

Abstract

5-Ethyl-, 5-vinyl-, 5-propyl-, and 5-allyl-2'-deoxyuridine (dUrd) had antiviral activity against herpes simplex type 1 and type 2 grown in HeLa TK(-) cells, in the order 5-vinyl-dUrd, 5-ethyl-dUrd, 5-propyl-dUrd, 5-allyl-dUrd, but they were inactive against a TK(-) mutant of herpes simplex type 1. The antiviral activity of these compounds could be partially reversed by thymidine. Except for 5-vinyl-dUrd, they were not toxic to WI-38 and HeLa TK(-) cells at a concentration of 25 muM. All four analogues inhibited the growth of herpes simplex type 1-transformed HeLa TK(-) cells at a concentration of 1 muM.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 185944      PMCID: PMC429699          DOI: 10.1128/AAC.10.1.119

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Synthesis of 5-vinyluridine and 5-vinyl-2'-deoxyuridine as new pyrimidine nucleoside analogs.

Authors:  R A Sharma; M Bobek
Journal:  J Org Chem       Date:  1975-08-08       Impact factor: 4.354

2.  On the mode of action of 5-vinyl-2'-deoxyuridine.

Authors:  P Langen; D Bärwolff
Journal:  Biochem Pharmacol       Date:  1975-10-15       Impact factor: 5.858

3.  Temperature-sensitive mutants of herpes simplex virus type 1 defective in lysis but not in transformation.

Authors:  R G Hughes; W H Munyon
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

4.  Virus type-specific thymidine kinase in cells biochemically transformed by herpes simplex virus types 1 and 2.

Authors:  D B Davis; W Munyon; R Buchsbaum; R Chawda
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

5.  5-Ethyl-2'-deoxyuridine: absence of effects on the chromosomes of human lymphocytes and fibroblasts in culture.

Authors:  S Singh; I Willers; H W Goedde
Journal:  Humangenetik       Date:  1974

6.  5-Ethyl-2'-deoxyuridine: evidence for incorporation into DNA and evaluation of biological properties in lymphocyte cultures grown under conditions of amethopterine-imposed thymidine deficiency.

Authors:  K M Swierkowska; J K Jasińska; J A Steffen
Journal:  Biochem Pharmacol       Date:  1973-01-01       Impact factor: 5.858

7.  A nonmutagenic thymidine analog with antiviral activity. 5-Ethyldeoxyuridine.

Authors:  M Swierkowski; D Shugar
Journal:  J Med Chem       Date:  1969-05       Impact factor: 7.446

8.  HeLa cells resistant to bromodeoxyuridine and deficient in thymidine kinase activity.

Authors:  S Kit; D R Dubbs; P M Frearson
Journal:  Int J Cancer       Date:  1966-01       Impact factor: 7.396

9.  5-allyl-2'-deoxyuridine inhibition of nucleoside phosphorylase in HeLa cells containing mycoplasma.

Authors:  J F Holland; R Korn; J O'Malley; H J Minnemeyer; H Tieckelmann
Journal:  Cancer Res       Date:  1967-10       Impact factor: 12.701

  9 in total
  21 in total

1.  5-Propyl-2'-deoxyuridine: a specific anti-herpes agent.

Authors:  E De Clercq; J Descamps; D Shugar
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.

Authors:  R F Schinazi; R T Scott; J Peters; V Rice; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

4.  Kinetic analysis in cell culture of the reversal of antiherpes activity of nucleoside analogs by thymidine.

Authors:  A Larsson; G Brännström; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

5.  Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells in vitro.

Authors:  M J Gill; J Samuel; L I Wiebe; E E Knaus; D L Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

6.  In vitro antiherpesviral activity of 5-alkyl derivatives of 1-beta-D-arabinofuranosyluracil.

Authors:  H Machida; S Sakata; A Kuninaka; H Yoshino; C Nakayama; M Saneyoshi
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

7.  Capacity of deoxycytidine to selectively antagonize cytotoxicity of 5-halogenated analogs of deoxycytidine without loss of antiherpetic activity.

Authors:  L M Fox; J A Mekras; C B Bagwell; S B Greer
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

8.  Synthesis and biological properties of 2'-deoxy-5-vinyluridine and 2'deoxy-5-vinylcytidine.

Authors:  S G Rahim; M J Duggan; R T Walker; A S Jones; R L Dyer; J Balzarini; E De Clercq
Journal:  Nucleic Acids Res       Date:  1982-09-11       Impact factor: 16.971

9.  Antiherpesviral activity and inhibitory action on cell growth of 5-alkenyl derivatives of 1-beta D-arabinofuranosyluracil.

Authors:  H Machida; A Kuninaka; H Yoshino; K Ikeda; Y Mizuno
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

10.  Acyclovir inhibition of Epstein-Barr virus replication.

Authors:  A K Datta; B M Colby; J E Shaw; J S Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.